These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Greenberg JI; Shields DJ; Barillas SG; Acevedo LM; Murphy E; Huang J; Scheppke L; Stockmann C; Johnson RS; Angle N; Cheresh DA Nature; 2008 Dec; 456(7223):809-13. PubMed ID: 18997771 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis. Song N; Huang Y; Shi H; Yuan S; Ding Y; Song X; Fu Y; Luo Y Cancer Res; 2009 Aug; 69(15):6057-64. PubMed ID: 19584297 [TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells. Lederle W; Stark HJ; Skobe M; Fusenig NE; Mueller MM Am J Pathol; 2006 Nov; 169(5):1767-83. PubMed ID: 17071599 [TBL] [Abstract][Full Text] [Related]
14. bFGF and PDGF-BB have a synergistic effect on the proliferation, migration and VEGF release of endothelial progenitor cells. Sufen G; Xianghong Y; Yongxia C; Qian P Cell Biol Int; 2011 May; 35(5):545-51. PubMed ID: 20961291 [TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Guo P; Hu B; Gu W; Xu L; Wang D; Huang HJ; Cavenee WK; Cheng SY Am J Pathol; 2003 Apr; 162(4):1083-93. PubMed ID: 12651601 [TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species. Lange S; Heger J; Euler G; Wartenberg M; Piper HM; Sauer H Cardiovasc Res; 2009 Jan; 81(1):159-68. PubMed ID: 18806276 [TBL] [Abstract][Full Text] [Related]
17. Taming of the wild vessel: promoting vessel stabilization for safe therapeutic angiogenesis. Reginato S; Gianni-Barrera R; Banfi A Biochem Soc Trans; 2011 Dec; 39(6):1654-8. PubMed ID: 22103503 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of platelet-derived growth factor-BB and vascular endothelial growth factor as prognostic factors for patients with fulminant hepatic failure. Takayama H; Miyake Y; Nouso K; Ikeda F; Shiraha H; Takaki A; Kobashi H; Yamamoto K J Gastroenterol Hepatol; 2011 Jan; 26(1):116-21. PubMed ID: 21175804 [TBL] [Abstract][Full Text] [Related]
19. Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells. Reinmuth N; Rensinghoff S; Raedel M; Fehrmann N; Schwöppe C; Kessler T; Bisping G; Hilberg F; Roth GJ; Berdel W; Thomas M; Mesters RM Int J Oncol; 2007 Sep; 31(3):621-6. PubMed ID: 17671690 [TBL] [Abstract][Full Text] [Related]
20. [Anti-angiogenesis effect of metronomic chemotherapy in multiple myeloma patients]. Guo LP; Zhou F; Wei W; Zhang YZ; Shi HT; Lin CH; Li L; Hou J Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):457-60. PubMed ID: 22967380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]